Literature DB >> 16770789

A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015.

Tim Byers1, Ermilo Barrera, Elizabeth T H Fontham, Lisa A Newman, Carolyn D Runowicz, Stephen F Sener, Michael J Thun, Sara Winborn, Richard C Wender.   

Abstract

BACKGROUND: The American Cancer Society has challenged the U.S. to reduce cancer mortality rates 50% over the 25 years from 1990 to 2015. The current report is an analysis and commentary on progress toward that goal through 2002, the midpoint of the challenge period.
METHODS: Cancer mortality rates were examined from 1990 through 2002, and projections to the Year 2015 were made. Cancer deaths that were prevented or deferred by the declining death rates were expressed as the difference between the observed and projected numbers of deaths and the numbers that would have been observed over that period had the 1990 death rates persisted.
RESULTS: Since 1990, cancer mortality rates have been declining in the U.S. by approximately 1% per year. Trends especially have been favorable for cancers of the breast, prostate, and colorectum and for lung cancer among men. Should this rate of decline continue over the coming decade, death rates from cancer will be approximately 23% lower in the Year 2015 than they were in 1990, and approximately 1.8 million deaths from cancer will have been prevented or deferred.
CONCLUSIONS: At this midpoint of the 25-year challenge period, it appears that fully reaching the goal will require substantial breakthroughs in cancer early detection and/or in cancer therapy. Between now and 2015, however, many more cancer deaths can be averted by concerted action to control tobacco and obesity, by redoubling efforts in mammography and colorectal screening, and by enacting policies to close gaps in access to cancer detection and treatment services.

Entities:  

Mesh:

Year:  2006        PMID: 16770789     DOI: 10.1002/cncr.21990

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Opinion: a personal note--40 years after the signing of the Cancer Act.

Authors:  Vincent T DeVita
Journal:  Nat Rev Clin Oncol       Date:  2011-11-01       Impact factor: 66.675

2.  Two hundred years of cancer research.

Authors:  Vincent T DeVita; Steven A Rosenberg
Journal:  N Engl J Med       Date:  2012-05-30       Impact factor: 91.245

3.  Computer-aided diagnosis for improved detection of lung nodules by use of posterior-anterior and lateral chest radiographs.

Authors:  Junji Shiraishi; Feng Li; Kunio Doi
Journal:  Acad Radiol       Date:  2007-01       Impact factor: 3.173

4.  The war on cancer: a report from the front lines.

Authors:  Gavin Melmed
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-10

Review 5.  Computer-aided diagnosis in medical imaging: historical review, current status and future potential.

Authors:  Kunio Doi
Journal:  Comput Med Imaging Graph       Date:  2007-03-08       Impact factor: 4.790

6.  Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.

Authors:  David Limsui; Robert A Vierkant; Lori S Tillmans; Alice H Wang; Daniel J Weisenberger; Peter W Laird; Charles F Lynch; Kristin E Anderson; Amy J French; Robert W Haile; Lisa J Harnack; John D Potter; Susan L Slager; Thomas C Smyrk; Stephen N Thibodeau; James R Cerhan; Paul J Limburg
Journal:  J Natl Cancer Inst       Date:  2010-06-29       Impact factor: 13.506

7.  Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy.

Authors:  Hiroaki Iwamoto; Hiroshi Kano; Takafumi Shimada; Renato Naito; Tomoyuki Makino; Suguru Kadomoto; Hiroshi Yaegashi; Kazuyoshi Shigehara; Kouji Izumi; Yoshifumi Kadono; Atsushi Mizokami
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

8.  Effectiveness of Vintage Hormone Therapy as Alternative Androgen Deprivation Therapy for Non-metastatic Castration-resistant Prostate Cancer.

Authors:  Hiroaki Iwamoto; Hiroshi Kano; Takafumi Shimada; Renato Naito; Tomoyuki Makino; Suguru Kadamoto; Hiroshi Yaegashi; Kazuyoshi Shigehara; Kouji Izumi; Yoshifumi Kadonoa; Atsushi Mizokami
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

9.  Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Karynsa Cetin; Jennifer L Beebe-Dimmer; Jon P Fryzek; Richard Markus; Michael A Carducci
Journal:  Urology       Date:  2009-12-06       Impact factor: 2.649

10.  How Well Have Projected Lung Cancer Rates Predicted the Actual Observed Rates?

Authors:  Qingwei Luo; Julia Steinberg; Xue Qin Yu; Michael Caruana; Karen Canfell; Dianne L O’Connell
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.